Octreotide Acetate
Who holds supplier records for Octreotide Acetate? 23 organisations hold a current record for Octreotide Acetate: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), China (4), United States (2), Italy (2) and 4 other countries (4); not recorded for 5.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Octreotide Acetate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/octreotide-acetate
Reading the evidence
- 23 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (23)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Octreotide Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 27990, 17678, 44397 · latest filing Jul 2026
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 37913 · latest filing Dec 2022
- ALP PHARM BEIJING CO LTDActive DMF 30992 · latest filing Oct 2016
- AMBIO INCUnited StatesActive DMF 27759 · latest filing Nov 2013
- AURO PEPTIDES LTDActive DMF 29448 · latest filing Jun 2015
- BACHEM AGCompany GMP cert on recordActive DMF 34145 · latest filing Sept 2019
- BCN PEPTIDES SASpainActive DMF 18740 · latest filing Sept 2005
- CHEMI SPAItaly Company GMP cert on recordActive DMF 19567 · latest filing Jun 2006
- CHEMICAL AND BIOPHARMACEUTICAL LABORATORIES OF PATRAS SINGLE MEMBER SACompany GMP cert on recordActive DMF 31277 · latest filing Dec 2016
- CHENGDU SHENGNUO BIOPHARM CO LTDChinaActive DMF 30249 · latest filing Sept 2016
- FRESENIUS KABI IPSUM SRLItaly Company GMP cert on recordActive DMF 34118 · latest filing Dec 2020
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChinaActive DMF 35816 · latest filing Nov 2021
- HARBIN JIXIANGLONG BIOTECH CO LTDActive DMF 39937 · latest filing May 2024
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 27729 · latest filing Dec 2013
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 36322 · latest filing Nov 2021
- PolyPeptide Laboratories (Sweden) ABSweden Company GMP cert on recordActive DMF 32863 · latest filing Jun 2018
- POLYPEPTIDE LABORATORIES INCUnited StatesActive DMF 14994 · latest filing Aug 2000
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 30131 · latest filing Dec 2015
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 43523 · latest filing Jan 2026
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChinaActive DMF 29710 · latest filing Oct 2017
- SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTDChinaActive DMF 44547 · latest filing Aug 2026
- TAPI NL BVNetherlandsActive DMF 17777 · latest filing Oct 2004
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 24288 · latest filing Nov 2010
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Octreotide Acetate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- HEMMO PHARMACEUTICALS PVT LTDInactive DMF 26330 · filed Jun 2012
- India · Inactive DMF 22068 · filed Oct 2008
- BACHEM AMERICAS INCInactive DMF 16760 · filed Aug 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Octreotide Acetate is a synthetic octapeptide that mimics natural somatostatin pharmacologically, inhibiting the secretion of several hormones. It is primarily used in the treatment of acromegaly and severe cases of diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide tumors.
Chemical identity
- IUPAC name
- acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- Canonical SMILES
- C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O.CC(=O)O.CC(=O)O
- InChIKey
- QWFYIFWTVZFPRY-LODIGNQBSA-N
- Synonyms
- Sandostatin API, bynfezia, mycapssa, octreolin, octreotide (as acetate), sandostatin, sms 201-995 ac, sms-201-995 ac, sms-201995-ac
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Somatostatin Analog
- Mechanism of action
- Somatostatin Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Octreotide Acetate?
23 organisations hold an active US FDA Type II Drug Master File or a CEP for Octreotide Acetate: Sun Pharmaceutical Industries Limited (India), Alembic Pharmaceuticals Limited (India), ALP PHARM BEIJING CO LTD, AMBIO INC (United States), AURO PEPTIDES LTD, BACHEM AG, BCN PEPTIDES SA (Spain) and CHEMI SPA (Italy), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Octreotide Acetate Drug Master Files are active?
Sun Pharmaceutical Industries Limited (DMF 27990, 17678), Alembic Pharmaceuticals Limited (DMF 37913), ALP PHARM BEIJING CO LTD (DMF 30992), AMBIO INC (DMF 27759), AURO PEPTIDES LTD (DMF 29448), BACHEM AG (DMF 34145), BCN PEPTIDES SA (DMF 18740) and CHEMI SPA (DMF 19567) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Octreotide Acetate records mean?
3 organisations have only inactive Type II DMFs for Octreotide Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Octreotide Acetate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Octreotide Acetate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.